A note about COVID-19. Learn more.

September 12, 2017 | Press

Pentec Health, Inc. Named One of the Fastest Growing Companies in the Philadelphia Region

Philly100 Logo Header

Pentec Health, a leader in patient specific and sterile compounding, has been recognized as one of the Philadelphia regions top 100 fastest-growing, privately-held companies. The 2017 award marks Pentec’s inclusion on the Philadelphia 100® for the seventh time in the past eight years. The Philadelphia 100® is considered to be the standard of excellence for entrepreneurial success in the region and is awarded by The Wharton Small Business Development Center at the Wharton School of the University of Pennsylvania, Entrepreneurs’ Forum of Greater Philadelphia and Philadelphia Media Network, publisher of The Philadelphia Inquirer, Daily News, and Philly.com.

“Our strength is in our engaged and brilliant workforce. They are committed to helping the company succeed by providing the best products and services for patients,” said Joseph Cosgrove, Chairman, President and CEO of Pentec Health. Mr. Cosgrove also stated, “The strategic focus on innovation is an integral part of our company’s unique entrepreneurial fiber and has been the catalyst which has led to Pentec Health’s long term sustainable growth.”

The 29th Annual Philadelphia 100® Awards Ceremony will be held Thursday, October 26, 2017, revealing the rankings and growth rates of the 100 honored companies. A complete alphabetical list of the winning companies with rankings will be posted on the Philadelphia100.com website by midnight of October 26th.

About Pentec Health
For over 34 years, Pentec Health has been an industry leader in providing patient-specific compounded sterile medications. Pentec Health’s medications are used for administration in dialysis centers, as well as providing in-home Specialty Infusion through nursing services and complex pharmaceutical products to patients who require access outside of a hospital setting. Pentec Health is now registered as an outsourcing facility, providing sterile compounds to meet the needs of the nation’s institutional healthcare segments. For more information, please visit http://www.pentechealth.com.

About the Philadelphia 100®
The Philadelphia 100® is a joint project of the Wharton Small Business Development Center, the Entrepreneurs’ Forum of Greater Philadelphia, and the Philadelphia Business Journal. The rankings are based on verified revenue growth, and the program’s evaluation has been carefully managed to ensure its fairness and integrity. As a result, ranking as a Philadelphia 100® company is highly competitive. For more on The Philadelphia 100®, please visit http://www.philadelphia100.com.

Pentec Health, Inc.
Shetal Vyas

Latest Insights

See More Insights